In the case of platelets, epigenetic modifications within the PAR-1 gene (F2R) – such as DNA methylation, histone modifications, and regulation by microRNAs (e.g., miR-126, miR-92a) – may potentially influence platelet activation and the progression of atherosclerosis. The gene discussed is MARK2; the disease is atherosclerosis.